In an exploratory subgroup analysis of the ALLIANCE trial, ZA showed a trend towards prolonged time to first on study SRE in patients who suffered from an SRE in advance to study entry (hazard ratio [HR], 0.56).
← all excerpts
Bone Health Issues in Patients with Prostate Cancer: An Evidence-Based Review.
1
—
—